Brinton Pharma to export Favipiravir to Gulf countries

Image
Press Trust of India New Delhi
Last Updated : May 18 2020 | 8:00 PM IST

Brinton Pharmaceuticalson Monday said it is planning to export antiviral drugFavipiravir to Gulf countries and will launch it in India after getting approval from theDrugs Controller General of India(DCGI).

Favipiravir is a generic version of Avigan of Fujifilm Toyama Chemical Co Ltd, Japan, a subsidiary of Fujifilm Corporation,Brinton Pharmaceuticals said in a statement.

The drug will be marketed by the company under the brand name 'Faviton'and will be available in 200mg and 400mg tablets, itadded.

"The company will besupplying the drug to the Gulf region countries and will launch it in India after getting approval from DCGI,"Brinton PharmaceuticalsChairman and MDRahul Kumar Darda said.

Recently, the Task Force for Repurposing of Drugs for COVID-19 formed by the government, has classified Favipiravir and Tocilizumab as the drugs that have shown maximum readiness and potential in the fight against the disease, he added.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 18 2020 | 8:00 PM IST

Next Story